#antibody — Wednesday, June 03, 2026 (1 items)
| 0 | 💬 0 |
Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica.
(nejm.org)
|
New England Journal of Medicine 2026-06-03 | #antibody #inflammation #immunotherapy #rheumatology |